Medicamen Biotech restricts trading for insiders ahead of September 2026 results announcement Back
<p>Medicamen Biotech Limited will close its trading window for designated persons, including their immediate relatives, from October 1, 2026, until 48 hours after the announcement of financial results for the quarter and half year ending September 30, 2026, in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015.</p>